Texas Administrative Code (Last Updated: March 27,2024) |
TITLE 26. HEALTH AND HUMAN SERVICES |
PART 1. HEALTH AND HUMAN SERVICES COMMISSION |
CHAPTER 261. INTERMEDIATE CARE FACILITIES FOR INDIVIDUALS WITH AN INTELLECTUAL DISABILITY OR RELATED CONDITIONS (ICF/IID) PROGRAM--CONTRACTING |
SUBCHAPTER J. SURROGATE DECISION-MAKING |
SECTION 261.287. Provider Responsibilities Regarding Surrogate Decision-Maker
Latest version.
-
(a) A community program provider must provide the following information to a person identified as a surrogate decision-maker in accordance with §9.286 of this division (relating to Surrogate Decision-Maker): (1) a description of the condition that the proposed treatment, medication, or procedure is intended to improve or cure; (2) a description of the proposed treatment, medication, or procedure, including: (A) the individual's need for it; and (B) the potential benefits and risks of it to the individual; (3) a description of any generally accepted alternatives to the proposed treatment, medication, or procedure, including the risks and potential benefits of the alternatives to the individual; (4) the reasons the alternatives were not proposed for the individual, if applicable; (5) the time frames involved, such as immediacy of the need for the proposed treatment, medication, or procedure and the length of time that consent will be effective; and (6) that the surrogate decision-maker may: (A) refuse to give consent or withdraw consent after it is given; (B) defer to a surrogate consent committee for a specific decision; and (C) withdraw as the surrogate decision-maker. (b) A community program provider must document in the individual's record: (1) the specific information provided to the surrogate decision-maker as described in subsection (a) of this section; (2) the decision made by the surrogate decision-maker, and: (A) if consent is given, include a copy of the written consent given by the surrogate decision-maker; or (B) if consent is denied, document the reason for the denial, if known; (3) withdrawal of consent after it is given by the surrogate decision-maker and, if known, the reason for the withdrawal; (4) deferral by the surrogate decision-maker for a specific decision and, if known, the reason for the deferral; and (5) withdrawal of the surrogate decision-maker and, if known, the reason for the withdrawal. Source Note: The provisions of this §261.287 adopted to be effective July 1, 2007, 32 TexReg 3856; transferred effective October 1, 2020, as published in the Texas Register August 28, 2020, 45 TexReg 6127